Quest’s Haystack MRD Wins FDA Breakthrough Status, Shows Exceptional ctDNA Sensitivity

Quest believes Haystack’s technical foundation and national reach make it stand apart from competitors.

 
• By Shubham Singh
  
The FDA’s breakthrough devices program is designed for medical devices and device-led combination products that provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating conditions. • Source: Shutterstock

More from In Vitro Diagnostics

More from Diagnostics